The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
The FDA has approved the at-home use of AstraZeneca's FluMist nasal spray vaccine. A prescription will still be required. The vaccines will be available from an on-line pharmacy next fall.
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...